Related Experiment Video

Updated: Jul 6, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Myocardial tumor necrosis factor-alpha expression in a sudden death due to dilated cardiomyopathy with

Irene Riezzo, Cristoforo Pomara, Margherita Neri

    International Journal of Cardiology
    |March 29, 2008
    PubMed

    Insights

    Sudden cardiac death in young adults can be linked to dilated cardiomyopathy. This study found high levels of tumor necrosis factor-alpha in heart tissue, suggesting its role in fatal outcomes.

    Area of Science:

    • Cardiovascular Pathology
    • Molecular Cardiology

    Background:

    • Dilated cardiomyopathy presents risks including arrhythmias, thromboembolism, and sudden death.
    • Elevated plasma tumor necrosis factor-alpha (TNF-α) is linked to poor prognosis in dilated cardiomyopathy patients.
    • Myocardial TNF-α expression correlates with increased mortality in experimental and clinical studies.

    Observation:

    • Presents a case of sudden death in a young man with endomyocardial fibrosis and dilated cardiomyopathy.
    • Investigated cardiac morphology and TNF-α expression in myocardial tissue from the fatal case.
    • Demonstrated strong positive myocytes reaction for TNF-α in heart specimens.

    Findings:

    • Myocardial tumor necrosis factor-alpha expression was significantly elevated in the fatal case.
    • Histological findings revealed endomyocardial fibrosis and positive myocytes reaction for TNF-α.
    • This suggests a potential role for TNF-α in the pathogenesis of sudden death in this condition.

    Implications:

    • Highlights the potential contribution of TNF-α to sudden cardiac death in dilated cardiomyopathy.
    • Suggests TNF-α as a potential therapeutic target for improving outcomes in dilated cardiomyopathy.
    • Emphasizes the importance of investigating molecular markers in unexplained sudden cardiac death cases.

    More Related Videos

    A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition08:38

    A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

    Published on: July 21, 2023

    Related Concept Videos

    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...